FIELD: medicine.
SUBSTANCE: there are described new reinforced biodegradable frames for soft tissue regeneration; there are also described methods for living tissue support, extension and regeneration, wherein the reinforced biodegradable frame is applied for relieving the symptoms requiring high durability and stability apart from patient's soft tissue regeneration. What is described is using the frames together with cells or tissue explants for soft tissue regeneration in treating medical prolapsed, e.g. rectal or pelvic prolapse, or hernia.
EFFECT: frames are adequately durable to be applicable for implantation accompanying the medical conditions requiring the structural support of the injured tissues.
14 cl, 19 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIODEGRADABLE MESH IMPLANT FOR SOFT TISSUE RESTORATION, IN PARTICULAR HERNIOPLASTY | 2020 |
|
RU2805364C2 |
| BIODEGRADABLE TWO-LAYER MATRIX FOR PREVENTING FORMATION OF POST-SURGICAL ADHESIONS, PARTICULARLY IN HERNIOPLASTY | 2020 |
|
RU2826997C2 |
| PEPTIDE CONJUGATED PARTICLES | 2014 |
|
RU2685186C2 |
| STENT WITH DOUBLE DRUG RELEASE | 2010 |
|
RU2552086C2 |
| SURGICAL IMPLANT | 2014 |
|
RU2691307C2 |
| IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS FOR USING THEM | 2016 |
|
RU2739033C2 |
| PEPTIDE CONJUGATED PARTICLES | 2013 |
|
RU2669346C2 |
| SURGICAL IMPLANT | 2014 |
|
RU2665188C2 |
| BONE IMPLANT MATRIX AND METHOD FOR PREPARING IT | 2009 |
|
RU2532385C2 |
| RAPAMICIN-RELEASING STENT | 2010 |
|
RU2563429C2 |
